These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 12243661)

  • 41. [Oral treatment of onychomycosis of the toe nails; comparison of cost effectiveness of griseofulvin, itraconazole, ketoconazole and terbinafine].
    Jacobs AE
    Ned Tijdschr Geneeskd; 1995 Apr; 139(17):904-5. PubMed ID: 7739744
    [No Abstract]   [Full Text] [Related]  

  • 42. Efficacy, safety and tolerability of terbinafine for Tinea capitis in children: Brazilian multicentric study with daily oral tablets for 1,2 and 4 weeks.
    Filho ST; Cucé LC; Foss NT; Marques SA; Santamaria JR
    J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):141-6. PubMed ID: 9784040
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Economic evaluation of antifungal agents in the treatment of toenail onychomycosis in Germany.
    Van Doorslaer EK; Tormans G; Gupta AK; Van Rossem K; Eggleston A; Dubois DJ; De Doncker P; Haneke E
    Dermatology; 1996; 193(3):239-44. PubMed ID: 8944348
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A risk-benefit assessment of the newer oral antifungal agents used to treat onychomycosis.
    Gupta AK; Shear NH
    Drug Saf; 2000 Jan; 22(1):33-52. PubMed ID: 10647975
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The use of systemic antimycotics in dermatotherapy.
    Niewerth M; Korting HC
    Eur J Dermatol; 2000 Mar; 10(2):155-60. PubMed ID: 10694319
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of oral antifungal agents for the treatment of superficial fungal infections in immunocompromised patients.
    Millikan LE
    Cutis; 2001 Jul; 68(1 Suppl):6-14. PubMed ID: 11499333
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and safety of terbinafine 1% solution in the treatment of interdigital tinea pedis and tinea corporis or tinea cruris.
    Lebwohl M; Elewski B; Eisen D; Savin RC
    Cutis; 2001 Mar; 67(3):261-6. PubMed ID: 11270304
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Are placebo-controlled trials of creams for athlete's foot still justified?
    Crawford F; Harris R; Williams HC
    Br J Dermatol; 2008 Sep; 159(4):773-9. PubMed ID: 18834482
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Consensus for the Treatment of Tinea Pedis: A Systematic Review of Randomised Controlled Trials.
    Ward H; Parkes N; Smith C; Kluzek S; Pearson R
    J Fungi (Basel); 2022 Mar; 8(4):. PubMed ID: 35448582
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of Terbinafine and Itraconazole Combination Therapy Versus Terbinafine or Itraconazole Monotherapy in the Management of Fungal Diseases: A Systematic Review and Meta-Analysis.
    Ramzi SHT; Arif SA; Majid A; Kumar S; Shumail H; Qudsia F; Zainab Y; Varrassi G; Khatri M
    Cureus; 2023 Nov; 15(11):e48819. PubMed ID: 38106696
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Costs of therapy for dermatophyte infections.
    Chren MM
    J Am Acad Dermatol; 1994 Sep; 31(3 Pt 2):S103-6. PubMed ID: 8077495
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Review: oral antifungal drugs promote cure of fungal infections of the foot.
    Harkless GE
    Evid Based Nurs; 2002 Oct; 5(4):108. PubMed ID: 12402811
    [No Abstract]   [Full Text] [Related]  

  • 53. Topical Application of
    Su RC; Leu JG; Chen YH; Chen CY; Yang YF; Yen CC; Chou SH; Liang YJ
    Life (Basel); 2022 Mar; 12(4):. PubMed ID: 35454998
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dermatology for the practicing allergist: Tinea pedis and its complications.
    Al Hasan M; Fitzgerald SM; Saoudian M; Krishnaswamy G
    Clin Mol Allergy; 2004 Mar; 2(1):5. PubMed ID: 15050029
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Common fungal infections of the feet in patients with diabetes mellitus.
    Tan JS; Joseph WS
    Drugs Aging; 2004; 21(2):101-12. PubMed ID: 14960127
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A systematic review of oral treatments for fungal infections of the skin of the feet.
    Bell-Syer SE; Hart R; Crawford F; Torgerson DJ; Young P; Tyrrell W; Williams H; Russell I
    J Dermatolog Treat; 2001 Jun; 12(2):69-74. PubMed ID: 12243661
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Systematic treatment of tinea pedis--evidence for treatment? A result of a Cochrane review].
    Haedersdal M; Svejgaard EL
    Ugeskr Laeger; 2003 Mar; 165(14):1436-8. PubMed ID: 12715671
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oral treatments for fungal infections of the skin of the foot.
    Bell-Syer SE; Hart R; Crawford F; Torgerson DJ; Tyrrell W; Russell I
    Cochrane Database Syst Rev; 2002; (2):CD003584. PubMed ID: 12076488
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral treatments for fungal infections of the skin of the foot.
    Bell-Syer SE; Khan SM; Torgerson DJ
    Cochrane Database Syst Rev; 2012 Oct; 10(10):CD003584. PubMed ID: 23076898
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oral treatments for fungal infections of the skin of the foot.
    Margarido Lda C
    Sao Paulo Med J; 2014; 132(2):127. PubMed ID: 24714996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.